Recruiting Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer NCT07125547 Conditions Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney-sparing, +14 more Locations The Second Hospital of Tianjin Medical University — Tianjin, Outside U.S., China View Trial Details
Completed A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) NCT03474107 Conditions Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more Locations UCI Chao Family Comprehensive Cancer Center — Orange, California, United States University of California — Sacramento, California, United States Innovative Clinical Research — Whittier, California, United States University of Colorado — Denver, Colorado, United States View all 158 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction. NCT00263107 Conditions Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +20 more Locations University of California, Davis — Sacramento, California, United States Johns Hopkins — Baltimore, Maryland, United States Centerra Health — Norfolk, Virginia, United States View Trial Details
